News
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
The toughest hillclimb in the world returned under picture-perfect conditions, and Ian Boswell and Illi Gardner turned in ...
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...
The toughest hillclimb in the world returned under picture-perfect conditions, and Ian Boswell and Illi Gardner turned in ...
O’Reilly Auto Parts will become the title sponsor for NASCAR’s second-tier national series when the Xfinity Series is renamed ...
The IVES AI 30 list is a group of 30 tech companies analysts led by Daniel Ives believe will define the future of the AI ...
7h
TipRanks on MSNMixed options sentiment in Pfizer with shareslittle changed
Mixed options sentiment in Pfizer (PFE), with shares up 2c, or 0.1%, near $25.16. Options volume relatively light with 28k contracts traded and ...
Mercedes-Benz USA (MBUSA) today announced the appointment of Greg Gates as Vice President of Network Development, effective ...
Inclacumab, which Pfizer obtained in its 2022 acquisition of Global Blood Therapeutics, failed to significantly lower pain ...
This is the latest hit for Pfizer’s sickle cell disease portfolio after pulling Oxbryta from the market in 2024.
Pfizer set about evaluating inclacumab in pair of phase 3 studies, dubbed Thrive. The Big Pharma terminated one of those ...
This episode of Pharma Pulse covers a new collaboration to expand access to GLP-1 therapies via LillyDirect, Pfizer’s Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results